Phase III randomized, double-blind, active-controlled study of momelotinib versus ruxolitinib in patients with myelofibrosis.

被引：0
作者：
Winton, Elliott F.
Devos, Timothy
Oh, Stephen T.
Platzbecker, Uwe
Wadleigh, Martha
Jun, Susie
Lee, Peter
Deng, Wei
Gupta, Vikas
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Univ Ziekenhuizen Leuven UZ Leuven, Leuven, Belgium
[3] Washington Univ, St Louis, MO USA
[4] TUD, Univ Hosp Carl Gustav Carus, Dresden, Germany
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Gilead Sci Inc, Foster City, CA USA
[7] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS7101
引用
收藏
页数：1
相关论文
共 50 条
  • [21] IncobotulinumtoxinA for Glabellar Frown Lines in Chinese Subjects: A Randomized, Double-blind, Active-Controlled Phase-3 Study
    Wu, Yan
    Roll, Susanna
    Klein, Gudrun
    Geister, Thorin L.
    Makara, Michael A.
    Li, Bi
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2023, 11 (05) : e4956
  • [22] Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial
    Reuter, Uwe
    Ehrlich, Marc
    Gendolla, Astrid
    Heinze, Axel
    Klatt, Jan
    Wen, Shihua
    Hours-Zesiger, Peggy
    Nickisch, Jacqueline
    Sieder, Christian
    Hentschke, Christian
    Maier-Peuschel, Monika
    CEPHALALGIA, 2022, 42 (02) : 108 - 118
  • [23] Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis
    Christiansen, Claus
    Chesnut, Charles H., III
    Adachi, Jonathan D.
    Brown, Jacques P.
    Fernandes, Cesar E.
    Kung, Annie W. C.
    Palacios, Santiago
    Levine, Amy B.
    Chines, Arkadi A.
    Constantine, Ginger D.
    BMC MUSCULOSKELETAL DISORDERS, 2010, 11
  • [24] The primary results from a randomized double-blind phase II study of rovadicitinib versus hydroxyurea in patients with myelofibrosis
    Pan, L.
    Xu, Z.
    Yu, W.
    Shen, X.
    Zhang, Z.
    Jiao, Z.
    Zhao, X.
    Hou, M.
    Du, X.
    Ma, H.
    Duan, M.
    Peng, H.
    Yang, M.
    Wang, W.
    Gong, T.
    Ding, D.
    Wang, D.
    Xiao, Z.
    ANNALS OF ONCOLOGY, 2024, 35 : S596 - S596
  • [25] Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled study
    dos Santos, Marcelo Rodrigues
    Nunes Alves, Maria-Janieire de Nazare
    Jordao, Camila Paixao
    Novaes Pinto, Caio Eduardo
    Souza Correa, Kelly Thayane
    de Souza, Francis Ribeiro
    Peixoto da Fonseca, Guilherme Wesley
    Tomaz Filho, Joaquim
    Costa, Marcel
    Rodrigues Pereira, Rosa Maria
    Negrao, Carlos Eduardo
    Pereira Barretto, Antonio Carlos
    AMERICAN HEART JOURNAL, 2021, 239 : 1 - 10
  • [26] Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis
    Claus Christiansen
    Charles H Chesnut
    Jonathan D Adachi
    Jacques P Brown
    César E Fernandes
    Annie WC Kung
    Santiago Palacios
    Amy B Levine
    Arkadi A Chines
    Ginger D Constantine
    BMC Musculoskeletal Disorders, 11
  • [27] PHASE 3 RANDOMIZED TRIAL OF MOMELOTINIB VERSUS RUXOLITINIB IN JAK INHIBITOR NAIVE PATIENTS WITH MYELOFIBROSIS: RESULTS OF THE SIMPLIFY-1 STUDY
    Gotlib, J. R.
    Kiladjian, J-J.
    Catalano, J. V.
    Devos, T.
    Egyed, M.
    Hellman, A.
    McLornan, D. P.
    Shimoda, K.
    Winton, E. F.
    Deng, W.
    Dubowy, R. L.
    Maltzman, J. D.
    Cervantes, F.
    Mesa, R. A.
    HAEMATOLOGICA, 2017, 102 : 320 - 320
  • [28] Subcutaneous Tanezumab versus NSAID for the Treatment of Osteoarthritis: Neurological Safety in a Randomized, Double-Blind, Active-Controlled, 80-Week Phase 3 Study
    Sandroni, Paola
    Gorson, Kenneth C.
    Low, Phillip A.
    Hunter, David J.
    Pixton, Glenn C.
    Fountaine, Robert J.
    Brown, Mark T.
    Viktrup, Lars
    West, Christine
    Verburg, Kenneth M.
    ANNALS OF NEUROLOGY, 2020, 88 : S244 - S244
  • [29] A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis
    Xue, Yan
    Qin, Xianghong
    Zhou, Liya
    Lin, Sanren
    Wang, Ling
    Hu, Haitang
    Xia, Jielai
    CLINICAL DRUG INVESTIGATION, 2016, 36 (12) : 985 - 992
  • [30] Phase 2 study of ruxolitinib in combination with 5-azacitidine in patients with myelofibrosis.
    Masarova, Lucia
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Jabbour, Elias
    Bose, Prithviraj
    Ohanian, Maro
    Zhou, Lingsha
    Pierce, Sherry
    Gergis, Romany
    Borthakur, Gautam
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    Daver, Naval Guastad
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345